Results 81 to 90 of about 8,454 (202)

Rabeprazole-induced acute interstitial nephritis: A case report

National Journal of Physiology, Pharmacy and Pharmacology, 2018
Rabeprazole, a proton-pump inhibitor (PPI), commonly used in the treatment of gastroesophageal reflux disease, a condition caused due to regurgitation of acid from the stomach to the esophagus.
Krishnapriya Raj, Shilpa Raj, Lakshmi R
doaj   +1 more source

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer

Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 375-380, February 2026.
A clinical drug–drug interaction (DDI) study was designed to evaluate the effect of single and multiple oral doses of encorafenib on the single oral dose pharmacokinetics (PK) of the cytochrome P450 (CYP) enzyme probe substrates, losartan (CYP2C9), midazolam (CYP3A4), caffeine (CYP1A2), omeprazole (CYP2C19), and dextromethorphan (CYP2D6) administered ...
Joseph Piscitelli, Micaela B. Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Kyle Matschke, Jason H. Williams   +6 more
wiley   +1 more source

Vonoprazan‐Containing Triple Therapy Based on Clarithromycin Susceptibility May Be Definitive Treatment Strategy for Eradication of Helicobacter pylori

JGH Open, Volume 10, Issue 2, February 2026.
ABSTRACT Aims Helicobacter pylori (H.pylori) eradication therapy often fails to eradicate clarithromycin (CAM)‐resistant strains. Individualized therapy with proton pump inhibitors and metronidazole instead of CAM could be effective for first‐line eradication based on CAM sensitivity tests. However, on the basis of these tests, whether vonoprazan (VPZ)
Masaki Murata, Shin'ichi Miyamoto, Noriko Hayashi, Misae Ogaya, Koki Kurouchi, Yoichi Asano, Yuki Yamazaki, Sumire Mori, Hiroaki Yaku, Hirokazu Okada, Yoshiko Nakano, Yoshiyuki Ota, Yuichi Yamaga, Satoru Iwamoto, Taro Ueo   +14 more
wiley   +1 more source

A novel risk factor associated with colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in addition to Antimicrobial Treatment [PDF]

, 2016
published_or_final_versio
Chau, PH, Chen, HKJ, Cheng, CCV, Ching, HCR, Ho, PL, Hung, FNI, Lee, WM, Ng, LMM, So, SYC, Wong, CYS, Wong, MWL, Yuen, KY   +11 more
core   +1 more source

Proton Pump Inhibitors Therapy in Children with Gastroesophageal Reflux [PDF]

, 2013
Proton pump inhibitors (PPI) has been widely used by clinicians to treat diseases that require suppression of gastric acid. PPI work by inhibiting the proton pump in gastric parietal cells.In adult patients, PPI hasbeen widely studied and showed ...
Hegar, B. (Badriul), Reynaldo, A. (Aldo)
core  

"Gastroesophageal reflux disease" [PDF]

, 2002
Geoffrey C. Wall is an Associate Professor of Pharmacy Practice in the College of Pharmacy and Health Sciences. He can be contacted at geoff.wall@drake.eduPROLOGUE: Gastroesophageal reflux disease (GERD) is a pathologic condition of injury to the ...
Jacoby, Henry I., Wall, Geoffrey C.
core   +1 more source

Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study

Frontiers in Pharmacology
Background: Laryngopharyngeal reflux disease (LPRD) is an extraesophageal syndromic manifestation of gastroesophageal reflux disease (GERD). Despite the increasing incidence of and concern about LPRD, treatment with proton pump inhibitors (PPIs) is ...
Yading Li, Yading Li, Mingxian Zheng, Yi Wang, Gaofan Xu, Yunyun He, Yue Wu, Xiao Wang, Yuyang Liu, Yujie Jiang, Xiaowen Liu, Yangyang Meng, Yixuan Yap, Shengliang Zhu, Cong He, Bingduo Zhou   +15 more
doaj   +1 more source

Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance [PDF]

, 2011
Enzymes are critically important in the transportation, metabolism, and clearance of most therapeutic drugs used in clinical practice today. Many of these enzymes have significant genetic polymorphisms that affect the enzyme's rate kinetics.
Alan H B Wu
core   +2 more sources

Variability of 24-hour pH-metry scores at patients with duodenal peptic ulcer after single dose of rabeprazole

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2010
Aim of investigation. To estimate antisecretory response to single dose of rabeprazole in patients with peptic ulcer (PUD) of duodenum by 24-hour intragastric pH-metry.Material and methods.
D. I. Abdulganiyeva
doaj  

Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP3S-tool [PDF]

, 2016
Background: The Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S-)tool was recently developed to screen for potentially inappropriate prescribing (PIP).
Boussery, Koen, Mattelin, Kristof, Mehuys, Els, PATTYN, EVA, Petrovic, Mirko, Somers, Annemie, Tommelein, Eline, Van Damme, Charlotte   +7 more
core   +1 more source